BioSpace News Archive

Business

Akari Therapeutics Strengthens Board With Two Senior Industry Appointments

The company appointed Michael Grissinger and Dr. Peter Feldschreiber to the Company’s Board of Directors with immediate effect.

January 23, 2018
·
6 min read
BioCapital

Altimmune Announces Notice of Allowance on Patent Covering Use of NasoShield in the U.S.

The Company has already been granted patents extending IP protection for intranasal administration of NasoShield in Europe and Japan.

January 23, 2018
·
4 min read
BioMidwest

KemPharm Receives Patent Grant for KP606, a Prodrug of Oxycodone

KemPharm was recently issued USPTO for its patent application related to KP606 entitled “Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxycodone, prodrugs, methods of making and use thereof.”

January 23, 2018
·
4 min read
Business

BioLife Solutions Announces SAVSU Alliance With World Courier

The combination of World Courier’s global logistics network and SAVSU’s patent pending.

January 23, 2018
·
5 min read
Business

Bone Therapeutics Provides Business Outlook and Announces its Financial Calendar for 2018

Bone Therapeutics today provides business outlook and its cash position end of 2017.

January 23, 2018
·
4 min read
BioCanCell Announces Terms of $25M Funding Round

The investment will be priced at NIS 1.60 per share ($0.46 at current exchange rates), reflecting a Company valuation of approximately $51 million on a fully-diluted basis.

January 23, 2018
·
3 min read
Genetown

Skyhawk Therapeutics Launches With $8M in Seed Financing to Advance Its Novel Platform and Portfolio of Small Molecules That Correct RNA Expression

Skyhawk today announced the close of $8M in seed funding led by major family and biotech investors, including Tim Disney, the Duke of Bedford, Alexandria Venture Investments, and other undisclosed private investors.

January 23, 2018
·
7 min read
Study Shows Superiority of PharmaJet Needle-Free Injector for Poliovirus Vaccine Administration

PharmaJet announced that a study was published in Heliyon Journal showing PharmaJet needle-free injection is superior to needle and syringe for fractional dose poliovirus vaccine campaigns.

January 23, 2018
·
2 min read
Drug Development

Voyager Therapeutics Announces FDA Clearance of Investigational New Drug Application for VY-AADC for Advanced Parkinson’s Disease

Pivotal Phase 2-3 program on track to dose the first patient during the second quarter of 2018.

January 23, 2018
·
7 min read
Pharm Country

Tonix Pharmaceuticals Receives Notice of Allowance for New U.S. Patent for the Active Ingredient in Tonmya (Cyclobenzaprine HCl Sublingual Tablets)

Tonix is in Phase 3 development of Tonmya, a FDA-designated Breakthrough Therapy for the treatment of PTSD.

January 23, 2018
·
6 min read